Page 62 - Sohini Das

Centre looking to phase out codeine-based cough syrups, select FDCs

The industry is divided on the issue of phasing out codeine-based cough syrups, which are used by many as intoxicants

DTAB to review 19 fixed-dose combinations drugs, codeine formulations today

CDSCO aims to phase out these combinations and codeine-based drugs in a phased manner

Ayushman Bharat: Patients prefer private hospitals for govt schemes

Despite accounting for 46% of hospital empanelments, private hospitals accounted for 54 per cent of 38 million hospital admissions under AB-PMJAY

Indian generic formulation-makers level of capex declining: Candle Partners

Candle Partners study shows that from the peak of 30% of gross block in FY16, the capex is down to 9-10% of gross block

Hospitals flag concern about new CGHS rates for patient admissions

Hospitals asked to give 20% discount on MRP of medicines, say term is unviable for them

Spike in fever cases: Dengue, malaria, swine flu take over from Covid-19

Some cities like Delhi and Mumbai are also witnessing cases of leptospirosis and gastroenteritis fevers

Singh brothers get 6-month jail term in Fortis-Daiichi Sankyo case

When the brothers did not pay the arbitral award enforced by the Delhi High Court, Daiichi had filed a special leave petition in the apex court in 2018

Can Roche stay ahead of the competition in the next 125 years?

Pharma giant Roche believes, its ability to reinvent itself through innovation was behind its success. Business Standard's Sohini Das and Nivedita Mookerji spoke to the members of its founding family

India sets up export promotion council for medical devices under DoP

India currently exports Rs. 23,766 crore (2021-22) of medical devices up from previous year Rs 19,736 crore

Land parcels of pharma PSUs find no takers, but momentum likely in few mths

In December 2019 the decision was revised to allow sale of land to private entities as well through a competitive bidding process

Govt forms 5-member committee to review pharma marketing practices

It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days

India's Covid vaccination programme stunning: Roche's Hoffmann, Duschmale

'They (the next 125 years) look more challenging than the past 125 years. The world has changed. We have to make quicker decisions'

Centre notifies new Medical Device Rules to smoothen licensing procedure

Allows self declaration on portal for licensing purposes

Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop

All Class A and Class B med device makers to switch to licensing regime within; many are dealing with slow pace of govt audits or simply not clearing them

India's first off-the-shelf cell therapy treatment for knee osteoarthritis

One injection will cost Rs 1.25 lakh with effects lasting for two years or more

Mankind Pharma files for IPO, could be second largest among pharma firms

The offer for sale is expected to be anywhere between Rs 5000-5500 crore, say sources

The SSI Mantra: India's own surgical robot boasts cheaper price tag

SSI Mantra has already been used for 22 complex procedures at Delhi hospital

India warming up to vast potential of crowd-funding for healthcare

Of the 1.3 million active patients in India, around 890,000 have given consent to be up for adoption

Essential medicines list updated, adds 34 new drugs and drops 26

Medicines to treat diabetes, HIV, TB, contraceptives, hormonal medicines included in National List of Essential Medicines

NLEM 2022: Analysts see no major impact pharma companies' growth

The 2022 revision of the NLEM came after seven years. Most drugs that have been now brought into the NLEM include anti-infectives, anti-diabetics, anesthetics, etc